Hm Prince

Hm Prince

Peter Maccallum Cancer Centre - Melbourne / Australia
Others
AD Scientific Index ID: 4396644
-
person_outline Hm Prince's MOST POPULAR ARTICLES
1-) Lenalidomide plus dexamethasone for relapsed or refractory multiple myelomaM Dimopoulos, A Spencer, M Attal, HM Prince, JL Harousseau, ...New England Journal of Medicine 357 (21), 2123-2132, 200717222007
2-) Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRL Piekarz, R Frye, M Turner, JJ Wright, SL Allen, MH Kirschbaum, J Zain, ...Journal of clinical oncology 27 (32), 5410, 20097922009
3-) Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaH Quach, D Ritchie, AK Stewart, P Neeson, S Harrison, MJ Smyth, ...Leukemia 24 (1), 22-32, 20106622010
4-) Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapyB Coiffier, B Pro, HM Prince, F Foss, L Sokol, M Greenwood, D Caballero, ...Journal of Clinical Oncology 30 (6), 631-636, 20127622012
5-) Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...The Lancet 394 (10214), 2096-2107, 2019696*2019